Vitrolife & Igenomix Brasil, part of Vitrolife Group

About Vitrolife & Igenomix Brasil, part of Vitrolife Group

Vitrolife Group is a leading global supplier of medical devices and genetic testing solutions. Dedicated to the reproductive health market since 1994, we have grown with a focus on product development, innovative research, consistent quality control, and acquisitions of innovative companies in the sector. In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarily for in vitro fertilization clinics. Together, we are now Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes, always with sustainability in mind. Based on science and advanced research capabilities, our goal is to provide products and services for the entire reproductive health journey, delivering consistent performance and guaranteed quality. We are currently approximately 1,100 people worldwide, headquartered in Gothenburg, Sweden. Our products and services are available in over 125 countries, through our presence in over 25 countries and a vast network of distributors for the rest of the world. Our mission is to be the leading provider of valuable solutions in reproductive health and to support customers with successful treatment outcomes.